Stanford inventors in the lab of Dr. Katrin Svensson have discovered an endogenous peptide hormone that shows promise in treating obesity and diabetes.
Researchers at Stanford have developed a methodology for deep learning-based image reconstruction by incorporating the physics or geometry priors of the imaging system with deep neural networks.
SparseGMM, is a new algorithm which is a novel statistical approach for identifying drug targets in cancer patients and other diseases by more accurately modeling biological pathways.
Stanford researchers have developed a novel approach to make a stable and active platinum-alumina catalyst that maintains high activity under harsh conditions.
Stanford researchers have developed a new controllable methodology for molecularly targeted ultrasound contrast agent production with pre-formed ligand-phospholipid bioconjugates.
Stanford researchers have developed an integrated printer/scanner platform to screen biofluids for bacterial pathogens and other cells of interest at the single cell level.
Vibrational spectroscopy, including infrared and Raman optical spectroscopy, is an instrumental technique for fingerprinting molecular structures and the chemical compositions of different materials.
Researchers led by Stanford University's Stephen Tsai have developed new design and manufacturing approaches for glueless/boltless joining of metallic grid and carbon composite skins.
Stanford researchers have designed a new 3-dimensional (3D) hydrogel cell culture system that models native tissue environment with precise control over gelation and degradation properties.
Stanford scientists in Dr. Paul Wender's lab have developed a novel method to synthesize tigilanol tiglate (EBC-46) and related compounds from readily available starting materials.
Researchers at Stanford University have discovered a novel target for the treatment of Lyme disease by blocking pathogen mimics of CD47. Lyme disease is caused by the bacterium Borrelia burgdorferi (Bb) and the current standard of care is treatment with antibiotics.
Researchers at Stanford have developed synthetic transcription elongation factors (Syn-TEFs) to treat proliferative diseases, including repeat expansion mutations in cancer.